Adamas Pharmaceuticals Inc (ADMS)

Common Stock

8.22  +0.06 (+0.74%)

After market: 8.3 +0.08 (+0.97%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2021-9-30)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
2017
(2017-12-31)
Revenue
88.19M74.46M54.64M34.05M570.00K
Cost Of Goods
2.09M2.04M2.47M630.00K20.00K
Gross Profit
86.11M72.42M52.17M33.41M550.00K
Operating Expenses
125.40M116.59M144.40M148.44M88.48M
Research and Development
6.88M9.75M30.03M39.30M27.17M
Selling, General, and Administrative Expenses
118.51M106.84M114.37M109.14M61.31M
Operating Income
-39.30M-44.16M-92.24M-115.02M-87.93M
Interest Income/Expense
-23.42M-13.24M-12.95M-15.98M-3.29M
Income Before Taxes
-62.70M-57.40M-105.19M-131.00M-91.22M
Income Tax
N/AN/A0.000.00-1.73M
Net Income
-62.70M-57.40M-105.19M-131.00M-89.49M
EBITDA
-38.70M-43.31M-91.03M-113.56M-86.74M
 
Per Share Data
EPS Diluted Total Ops
-1.70-2.03-3.80-4.87-3.97
Non GAAP EPS
N/A-2.02-3.80-4.89-3.96
 
Statistics
Gross Profit Margin
97.64%97.26%95.48%98.12%96.49%
Profit Margin
-71.10%-77.09%-192.51%-384.73%-15700.00%
Operating Profit Margin
-44.57%-59.31%-168.81%-337.80%-15426.32%

All data in USD

Charts